Biogen Corp (BIIB) - Periode bali modal bisnis
Biogen Inc. (BIIB) is expanding its biosimilar portfolio to hedge against patent risks. The drug development process is accelerating through the integration of AI into molecular analysis. The company's weighted average P/E clearly confirms these trends, with the current level sitting around 106.70. However, high promotion costs for Alzheimer's therapy are temporarily limiting operating margin growth.
Rincian analitis perusahaan Biogen Inc.
- kuotasi lan prakiraan analis:
- indikator kapitalisasi pasar:
- data kapitalisasi buku:
- data liabilitas lan likuiditas perusahaan:
Utang marang Modal Biogen Inc.|BIIB - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal Biogen Idec|BIIB - Gunggung utang perusahaan|Rasio utang marang aset resik Biogen Inc.|BIIB - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Biogen|Rasio likuiditas darurat biogen.com
- data bathi bisnis lan rasio investasi:
BIIB - Bathi resik|Bathi mangsa ngarep Biogen Inc.|BIIB - Koefisien rega marang bathi|Kapitalisasi marang proyeksi bathi Biogen Inc|BIIB - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Biogen Inc.|BIIB - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Biogen|BIIB - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan biogen.com|BIIB - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Biogen Inc.
Analisis umum perusahaan:biogen.com - BIIB
Biogen Inc. possesses high resilience to external shocks due to the humanitarian status of its developments in neurodegeneration. The P/E ratio quantifies the market value of this advantage by comparing the current share price to annual net income. This multiple determines the investment payback period and the premium paid for future growth. By analyzing the price-to-earnings trend, an investor can distinguish the issuer's fundamental strength from short-term speculation.
Pesaing wigati
Rasio rega marang bathi NBIX|Pangali P/E RGC|Periode bali modal bisnis Axsome|Rasio rega marang bathi ACADIA Pharmaceuticals Inc ACAD|Xenon Corp (XENE) - Kapitalisasi marang bathi|Viking Therapeutics - Pangali P/E|Rasio kapitalisasi marang bathi resik supernus.com (SUPN)|CPRX: Pangali P/E|Kapitalisasi marang bathi Denali (DNLI)|Rasio rega marang bathi Harmony Pharma|Pangali rega marang bathi BHVN (Biohaven Corp)|Koefisien rega marang bathi AMLX (Amylyx Pharmaceuticals)|TRVI (trevitherapeutics.com) - Nilai perusahaan marang bathi resik|Pangali P/E PRAX (Praxis Precision Medicines, Inc.)|Periode bali modal bisnis Anavex (AVXL)|CBLL - Rasio rega marang bathi|PRTA (Prothena Corporation) - Pangali rega marang bathi|ALEC: Pangali P/E|Koefisien rega marang bathi annexonbio.com|Koefisien rega marang bathi OMER|Neurogene Inc (NGNE) - Periode bali modal bisnis|Pangali P/E ACIU|Rasio rega marang bathi VYGR (Voyager Corp)|Pangali P/E NMRA (Neumora Therapeutics)|Periode bali modal bisnis scilexholding.com (SCLX)|Tevogen Bio - Pangali P/E|Periode bali modal bisnis Alpha Cognition ACOG|CGTX: Pangali P/E|IKT (Inhibikase Pharma) - Rasio rega marang bathi|Rasio rega marang bathi Cassava Sciences, Inc.|Pangali rega marang bathi ASRT (Assertio Therapeutics)|Pangali P/E COYA|VTGN - Kapitalisasi marang bathi|Ovid Therapeutics - Koefisien rega marang bathi|Pangali P/E Acumen Pharmaceuticals, Inc ABOS|CRVO - Rasio rega marang bathi|Nilai perusahaan marang bathi resik ATHE (Alterity Therapeutics)|clene.com (CLNN) - Rasio rega marang bathi|Kapitalisasi marang bathi PepGen (PEPG)|JUNS (Jupiter Neurosciences) - Pangali P/E|Rasio rega marang bathi RLMD|Pangali P/E ANVS|Periode bali modal bisnis gracetx.com|Rasio rega marang bathi Firefly Neuroscience AIFF|ANEW Medical (KLTO) - Kapitalisasi marang bathi|NeuroSense Therapeutics, Ltd. - Pangali P/E|Rasio kapitalisasi marang bathi resik Reviva Pharmaceuticals, Inc. (RVPH)|MTVA: Pangali P/E|Kapitalisasi marang bathi neuraxis.com (NRXS)|Rasio rega marang bathi Helius Medical Technologies, Inc.|Pangali rega marang bathi PASG (Passage Bio Corp)|Koefisien rega marang bathi NEUP (Neuphoria Therapeutics Inc.)|NERV (Minerva) - Nilai perusahaan marang bathi resik|Pangali P/E ATHA (Athira Pharma, Inc.)|Periode bali modal bisnis addextherapeutics.com (ADXN)|ALZN - Rasio rega marang bathi|CYCN (Cyclerion Therapeutics) - Pangali rega marang bathi|PTIX: Pangali P/E|Koefisien rega marang bathi Pasithea Therapeutics Corp.|Koefisien rega marang bathi CRGT|avenuetx.com (ATXI) - Periode bali modal bisnis|Pangali P/E BCLI|Rasio rega marang bathi CARA (Cara Therapeutics Inc.)|Pangali P/E CHRO (Chromocell Therapeutics Corporation)|Periode bali modal bisnis Eliem Therapeutics, Inc. (ELYM)|Intra-Cellular - Pangali P/E|Periode bali modal bisnis longboardpharma.com LBPH|MRNS: Pangali P/E|NKGN (NKGen Biotech Inc) - Rasio rega marang bathi|Rasio rega marang bathi NeuroBo|Pangali rega marang bathi SAGE (Sage Therapeutics Inc)|Pangali P/E SNPX|TRVN - Kapitalisasi marang bathi|Vigil Neuroscience, Inc. - Koefisien rega marang bathi|Pangali P/E anewmeds.com WENA|CERE - Rasio rega marang bathi
